Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE THIERRY BAQUE : revenue, balance sheet and financial ratios

SELARL PHARMACIE THIERRY BAQUE is a French company founded 20 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in OSSEJA (66340), this company of category PME shows in 2025 a net income negative of -120 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE THIERRY BAQUE (SIREN 483910147)
Indicator 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net income -120 232 € -196 746 € 803 € 103 264 € 10 184 € -32 052 € 4 677 € 12 354 € -37 827 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2025, SELARL PHARMACIE THIERRY BAQUE records a net loss of 120 k€. This deficit will reduce equity on the balance sheet.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-120 232 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1.214%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

63.191%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

28.3%

Solvency indicators evolution
SELARL PHARMACIE THIERRY BAQUE

Sector positioning

Debt ratio
1.21 2025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Excellent

In 2025, the debt ratio of SELARL PHARMACIE THIERRY ... (1.21) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
63.19% 2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Good -13 pts over 3 years

In 2025, the financial autonomy of SELARL PHARMACIE THIERRY ... (63.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 29.10. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

29.099

Liquidity indicators evolution
SELARL PHARMACIE THIERRY BAQUE

Sector positioning

Liquidity ratio
29.1 2025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Watch -9 pts over 3 years

In 2025, the liquidity ratio of SELARL PHARMACIE THIERRY ... (29.10) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of SELARL PHARMACIE THIERRY BAQUE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE THIERRY BAQUE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE THIERRY BAQUE

What is the revenue of SELARL PHARMACIE THIERRY BAQUE ?

The revenue of SELARL PHARMACIE THIERRY BAQUE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE THIERRY BAQUE profitable?

SELARL PHARMACIE THIERRY BAQUE recorded a net loss in 2025.

Where is the headquarters of SELARL PHARMACIE THIERRY BAQUE ?

The headquarters of SELARL PHARMACIE THIERRY BAQUE is located in OSSEJA (66340), in the department Pyrenees-Orientales.

Where to find the tax return of SELARL PHARMACIE THIERRY BAQUE ?

The tax return of SELARL PHARMACIE THIERRY BAQUE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE THIERRY BAQUE operate?

SELARL PHARMACIE THIERRY BAQUE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.